NAGY, Balazs

  • Increase font size
  • Default font size
  • Decrease font size
Home Publications

Publications

Print

PhD theses

Nagy B: Risk adjustment for the allocation of health care resources in Hungary - development of the capitation payment formula (2009)

Book Chapter - Hungarian

Nagy B, Inotai A: "A hasznosság fogalma az egészség-gazdaságtanban" 5. fejezet. In: szerk: Inotai A - Lovas N - Kaló Z: "Az egészségnyereség mérése a betegek értékelése alapján" 2014, SpringMed Kiadó, Budapest ("Concept of utility in health economics" Chapter 5 In edt.: Inotai A - Lovas N - Kaló Z: "Measurement of patient reported outcomes in health care")

Nagy B, Dózsa Cs: "Az egészségbiztosítás" 10. fejezet In: szerk.: Gulácsi L: "Egészség-gazdaságtan" 2005, Medicina Könyvkiadó, Budapest. („Health Insurance” Chapter 10 In: edt.: Gulácsi L: „Health Economics” 2005, Medicina Könyvkiadó, Budapest) 

Publication in English

NagyB, Setyawan J, Coghill D, Soroncz-Szabó T, Kaló Z, Doshi & Jalpa A. A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder, Expert Review of Pharmacoeconomics & Outcomes Research, (2016) DOI: 10.1080/14737167.2017.1271325  

Nagy B, Zsolyom A, Nagyjanosi L, Meresz G, Steiner T, Papp E, Dessewffy Z, Jermendy G, Winkler G, Kalo Z, Voko Z. Cost-effectiveness of a risk based secondary screening program of type 2 diabetes. Diabetes Metab Res Rev. 2016 32: 710-729 

Ágh T, Pawaskar M, Nagy B, Lachaine J, Vokó Z. The cost-effectiveness of lisdexamfetamine dimesylate for the treatment of binge eating disorder in the United States. Clinical Drug Investigation 36(4):305-312 

Nagy B: Improving the allocation of health care resources in Poland. World Health Organization Regional Office for Europe. Copenhagen, 2015 

Nagy B, Timár Gy, Józwiak-Hagymásy J, Kovács G, Merész G, Vámossy I, Ághc T, László Á, Vokó Z, Kaló Z: The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. European Journal of Obstetrics & Gynecology and Reproductive Biology. Available online 31 January 2014 

Nagy B, Brennan A, Brandtmüller Á, Thomas S, SD Sullivan, R Akehurst: Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer’s disease in UK using MMSE- and ADL-based models, International Journal of Geriatric Psychiatry, 2011 26:5 483-94

Rózsa S, Brandtmüller Á, Nagy B, Brennan A, Akehurst R. The psychometric properties of ADCS - Activities of Daily Living Inventory and comparison of different ADL scores. ScHARR Discussion papers 2009, No. 09/05

Nagy B, Brandtmüller Á: Implementing risk adjusted capitation payments with health care reforms in Hungary, Competitio, 2008; 8:2 147-160

Publication in Hungarian

Kaló Z, Boncz I, Dank M, Kóczián K, Molnár MJ, Nagy B, Németh Gy, Pitter J, Zelei T. Health Economic Aspects of Personalized Medicine: Do Personalized Technologies Reduce Health Expenditure? (in Hungarian) IME. 2014. 13. 5. 41-45. 

Orosz É, Merész G, Nagy B Investment in human capital: falling behind the developed countries? Educatio 2013 22(2) 159-176 

Inotai A, Nagy B, Kaló Z. Biosimilars and evidence based decision making in Central Eastern European countries. (Orvostovábbképző Szemle) 2012. 19: 69-73.

Nagy B, Nagyjánosi L, Nagyistók Sz, Józwiak-Hagymásy J, Merész G, Papp E, Dessewffy Z, Jermendy György, Winkler G, Kaló Z, Vokó Z Health economic modell to assess the screening, treatment and management strategies of diabetes. Diabetologia Hungarica, 2012; 20 (4): 245-255

Nagy B, Merész G. Role of risk-sharing in health care: efficiency and risk selection. Health Care Management Review (Egészségügyi Gazdasági Szemle), 2012; 50(4): 42-48. 

Kaló Z, Nagy B Methodological questions in assessing the cost effectiveness of prevention programs, Health Care Management Review (Egészségügyi Gazdasági Szemle) 2012; 50:1 29-31 

Nagy B, Kaló Z: Managed Care. In: Health Economic Syllabus II. Medical Trubune 2010. 

Nagy B: Capitation. In: Health Economic Syllabus II. Medical Trubune 2010.

Nagy B, Kaló Z: Budget Impact Analysis. In: Health Economic Syllabus II. Medical Trubune 2010.

Nagy B: Resource allocation in Hungarian health care - Is there a missing link? Economic Review (Közgazdasági Szemle) 2010; 57:4 337-353

Nagy B, Brandtmüller Á, Dózsa Cs: The redistributive role of state in the English and Dutch health care market: Is there another way? Social Science Research (Társadalomkutatás) 2009; 27: 2117-2138

Nagy B, Brennan A, Skultéty L, Nagy J, Szentesi A, Dessewffy Z, Kalotai Z: The cost effectiveness of rivastigmine transdermal patch in the management of patients with mild and moderate Alzheimer’s disease Journal of Informatics and Management in Health Care (Informatika és Menedzsment az Egészségügyben) 2009; 8:3 40-45

Nagy B, Rakonczai P, Gulácsi L: Application of statistical methods to calculate capitation payments in the Hungarian health care. Hungarian Statistical Review (Statisztikai Szemle) 2008 – 86:4 321-341

Nagy B, Rakonczai P, Sipos J: Predicting health care expenditures with demographic characteristics for designing capitation payments in Hungary. Journal of Informatics and Management in Health Care (Informatika és Menedzsment az Egészségügyben) 2008; 7:Egészség-gazdaságtani különszám 5-9

Read more...